Emergent BioSolutions (EBS) PT Raised to $112 at Wells Fargo
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $4.54 -1.09%
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Wells Fargo analyst David Maris raised the price target on Emergent BioSolutions (NYSE: EBS) to $112.00 (from $110.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Aebi Schmidt Holding AG (AEBI) PT Raised to $17 at DA Davidson Following Q2 Results
- Johnson Rice Upgrades Magnolia Oil & Gas Corp. (MGY) to Accumulate
- Cullinan Oncology Inc. (CGEM) PT Raised to $27 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
